Title: Study of Cardiovascular Risk Factors in Patients of Diabetes type 2 with Special Reference to Sex Differences
Authors: Gosai. Kanugir. R., Gosai. Jigarkumar. B.
DOI: https://dx.doi.org/10.18535/jmscr/v5i4.216
Abstract
Objective: To assess the sex differences in the prevalence of cardiovascular risk factors among patients with type 2 diabetes attended at tertiary care centre.
Material & Methods: A cross-sectional study was performed among the type2 diabetes patients attending a tertiary care centre .We collected all data on preformed proforma regarding various risk factors for cardiovascular diseases in form of BMI, hypertension, dyslipidemia, smoking, alcohol consumption and glycemic control (HbA1c >8% considered poor control) with prior informed consent. Data was analysed using SPSS, version 16.0.
Results: Risk factors among 100 patients (80% males; mean age 54 years) patients were obesity (84%), poor glycemic control (32%), hypertension (34%), dyslipidemia (20%), smoking (61%) and consumption of alcohol (52%), respectively. Women had a higher prevalence of poor glycemiccontrol (40% vs 30%) and dyslipidemia (30% vs 17.5%) while men had a higher prevalence of smoking (75%) and alcohol consumption (65%). There were no sex differences in prevalence of hypertension and obesity.
Conclusion: Cardiovascular risk factors were highly prevalent among patients with type 2 diabetes attending a tertiary care centre in India, with different risk profiles among men and women. We recommend a specific approach as per prevalence of sex specific risk factors in planning interventions to reduce the risk of cardiovascular disease
Keywords: sex differences, cardiovascular risk factors, type 2 diabetes.
References
1. Boutayeb A, BoutayebS. The burden of non communicable diseases in developing countries. Int J Equity Health2005; 4:2.
2. International Diabetes Federation. IDF Diabetes Atlas. 5th ed, 2012 Update. Unwin N, Whiting D, Guariguata L, et al., eds. Brussels, Belgium: International Diabetes Federation, 2012.http://www.eat-las.idf.org/diabetesatlas/5e/update 2012. Accessed November 15, 2013.
3. Kannel WB, McGee DL. Diabetes and cardiovascular disease.The Framingham study. JAMA1979; 241:2035–8.
4. Moss SE, Klein R, Klein BE. Cause-specificmortality in a population-based study of diabetes. Am J Public Health1991; 81:1158–62.
5. Ramachandran A, Snehalatha C, LathaE, Satyavani K, Vijay V. Clustering of cardiovascular risk factors in urban Asian Indians. Diabetes Care1998; 21:967–71.
6. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. JAMA2007; 297:286–94.
7. Becker A, Bos G, deVegt F, etal.Cardiovascular events in type 2 diabetes: comparison with nondiabetic individuals without and with prior cardiovascular disease: 10-year follow-up of the Hoorn Study. Eur Heart J2003; 24:1406–13.
8. Castanho VS, Oliveira LS, Pinheiro HP, et al. Sex differences in risk factors for coronary heart disease: a study in Brazilian population. BMC Public Health,2001; 1:3.
9. Jousilahti P, Vartiainen E, TuomilehtoJ, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease. A prospective follow-up study of 14786 middle-aged men and women in Finland. Circulation1999; 99:1165–72.
10. Patnaik L, Pattnaik S, Ghosh T, Sahoo AK, Sahu T. Coronary heart disease risk factors among diabetic patients attending a tertiary care hospital – a cross sectional study. Internet J Epidemiol2013; No.1.
11. Misra A, Chowbey P, Makkar BM, et al., for Consensus Group. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physicians India2009; 57:163–70.
12. Chalmers J, MacMahon S, Mancia G, et al. 1999 World Health Organization – International Society of Hypertension Guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization.ClinExp Hypertens1999; 21:1009–60.
13. United States Department of Veteran Affairs.VA/DoD Clinical Practice Guidelines.Management of Dyslipidemia (LIPIDS) (2006).Available at:http://www.healthquality.va.gov/dyslipidemia_lipids.asp.Accessed on December 3, 2013.
14. deKoning L, Merchant AT, Pogue J, Anand SS. Waist circumference and waist-to-hip ratio as predictors of cardiovascular events: meta-regression analysis of prospective studies. Eur Heart J 2007; 28:850–6.
15. Gaziano TA, Reddy KS, Paccaud F, Horton S, Chaturvedi V. Cardiovascular disease. In: Jamison DT, Breman JG, Meashan AR, et al. eds. Disease control priorities in developing countries. New York: Oxford University Press, 2006: 645–62.
16. Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J2011; 17:640–6.
17. Kempler P. Learning from large cardiovascular clinical trials: classical cardiovascular risk factors. Diabetes Res Clin Pract2005; 68(Suppl. 1):S43–7.
18. Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; for the STROBE Initiative. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet2007; 370:1453–7.
19. Strom Williams Joni L, Lynch Cheryl P, Winchester Rhonda, Thomas Leslie, Keith Brad, EgedeLeonard E. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes. Diabetes Technology and Therapeutics2014; 16:421-427.